CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


03-June-2014
Cerilliant now offers Certified Spiking Solutions® of the antiepileptic internal standards Oxcarbazepine-13C6 and 10,11-Dihydro-10-Hydroxycarbamazepine-13C6

Oxcarbazepine-13C6, 100 ug/mL, O-039
100 µg/mL in Acetonitrile

This stable-labeled internal standard is suitable for use in quantitation of oxcarbazepine levels or isotope dilution methods by GC/MS or LC/MS for applications in pain prescription monitoring, clinical toxicology, therapeutic drug monitoring or urine drug testing. Oxcarbazepine, marketed under the trade name Trileptal®, is an anticonvulsant developed and prescribed for treatment of epilepsy. In recent years, Oxcarbazepine has shown efficacy in treatment of mood disorders.

(±)-10,11-Dihydro-10-Hydroxyca D-104
100 µg/mL in Acetonitrile

Also known as monohydroxy carbamazepine (MHC), 10,11-Dihydro-10-Hydroxycarbamazepine is a pharmacologically active, primary metabolite of oxcarbazepine in urine. Oxcarbazepine, sold under the trade name Trileptal®, is an antiepileptic drug used for the treatment of epilepsy and mood disorders. This stable-labeled internal standard is suitable for quantitation of MHC levels in urine, serum, or plasma by LC/MS or GC/MS for pain prescription monitoring, clinical toxicology, therapeutic drug monitoring or urine drug testing applications.



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn